Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Human Pathology
|
July 19, 2014
Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma
Jun-qing Zhang, Qing-he Yao, Yong-qin Kuang, et al.
European Journal of Medicinal Chemistry
|
May 19, 2018
From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4
Ding-Ding Gao, Hui-Xia Dou, Hai-Xia Su, et al.
European Journal of Medicinal Chemistry
|
March 25, 2019
Corrigendum to "From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4" [Ejmech 154 (2018) 44-59]
Ding-Ding Gao, Hui-Xia Dou, Hai-Xia Su, et al.
The American Journal of Chinese Medicine
|
February 13, 2026
Rhein Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting the Microglial NLRP3 Inflammasome/Pyroptosis Axis and Regulating Microglial M1/M2 Phenotypes
Xun Li, Yan Li, Wei-Peng Jing, et al.
Zhonghua Yi Xue Za Zhi
|
February 9, 2010
[A hospital-wide intervention program to optimize the utilization quality of carbapenems and glycopeptides]
Bin Cao, Li-ying Sun, Kun Liu, et al.
Science Bulletin
|
January 19, 2023
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)
Linong Ji, Weihong Song, Hui Fang, et al.
Translational Psychiatry
|
June 23, 2026
Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation
Fabiana Oliveira, Christina Papa, Tobias Hagemann, et al.
Science Bulletin
|
January 19, 2023
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)
Weiping Jia, Jianhua Ma, Heng Miao, et al.
Journal of Human Genetics
|
February 28, 2009
Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association
Kazuaki Miyake, Woosung Yang, Kazuo Hara, et al.
Nature Genetics
|
August 20, 2008
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Kazuki Yasuda, Kazuaki Miyake, Yukio Horikawa, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Human Pathology
|
July 19, 2014
Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma
Jun-qing Zhang, Qing-he Yao, Yong-qin Kuang, et al.
European Journal of Medicinal Chemistry
|
May 19, 2018
From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4
Ding-Ding Gao, Hui-Xia Dou, Hai-Xia Su, et al.
European Journal of Medicinal Chemistry
|
March 25, 2019
Corrigendum to "From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4" [Ejmech 154 (2018) 44-59]
Ding-Ding Gao, Hui-Xia Dou, Hai-Xia Su, et al.
The American Journal of Chinese Medicine
|
February 13, 2026
Rhein Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting the Microglial NLRP3 Inflammasome/Pyroptosis Axis and Regulating Microglial M1/M2 Phenotypes
Xun Li, Yan Li, Wei-Peng Jing, et al.
Zhonghua Yi Xue Za Zhi
|
February 9, 2010
[A hospital-wide intervention program to optimize the utilization quality of carbapenems and glycopeptides]
Bin Cao, Li-ying Sun, Kun Liu, et al.
Science Bulletin
|
January 19, 2023
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)
Linong Ji, Weihong Song, Hui Fang, et al.
Translational Psychiatry
|
June 23, 2026
Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation
Fabiana Oliveira, Christina Papa, Tobias Hagemann, et al.
Science Bulletin
|
January 19, 2023
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)
Weiping Jia, Jianhua Ma, Heng Miao, et al.
Journal of Human Genetics
|
February 28, 2009
Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association
Kazuaki Miyake, Woosung Yang, Kazuo Hara, et al.
Nature Genetics
|
August 20, 2008
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Kazuki Yasuda, Kazuaki Miyake, Yukio Horikawa, et al.
Page
of 11